missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies 3-Deazaneplanocin A
Epigenetic modifier; Inhibits histone EZH2 lysine methyltransferase
Brand: STEMCELL Technologies 72324
This item is not returnable.
View return policy
Description
- Deazaneplanocin A (DZNep) is an inhibitor of lysine methyltransferases, particularly EZH2
- DZNep therefore acts as an epigenetic modifier, specifically inhibiting the trimethylation of Histone 3, Lysine 27, by depleting levels of EZH2
- (Miranda et al.), Tan et al.), Tseng et al.)
- Enables chemical reprogramming (without genetic factors) of mouse embryonic fibroblasts to induced pluripotent stem (iPS) cells, in combination with CHIR99021, Forskolin, VaLproic Acid, Tranylcypromine, and E-616452, by increasing OCT4 expression at later stages of reprogramming (Hou et al.)
- Reactivation of XIST-dependent inactive X chromosomes in human embryonic stem cells (Diaz Perez et al.)
- Inhibits self-renewal of glioblastoma multiforme cancer stem cells (Suva et al.)
- Inhibits survival of acute myeloid leukemia blast cells, in combination with a histone deacetylase inhibitor (Fiskus et al.)
Specifications
102052-95-9 | |
1 mg | |
≥98% |
DZNep; NSC 617989 | |
C12H14N4O3 |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction